Heraeus acquires Mo-Sci and ETS Technology Holdings
The Heraeus Group has reached an agreement to acquire Mo-Sci Corp. and ETS Technology Holdings, the German conglomerate announced this week.
Mo-Sci is a supplier of glass microspheres, fibers and powders for medical devices, while ETS is the developer of the bioactive glass fiber wound care product Mirragen, an FDA approved synthetic absorbable skin substitute.
The companies, both located in Rolla, Missouri, will join the health and medical technology portfolio of Heraeus Group based in Hanau, Germany. The deal is expected to close by the end of 2021.
“In all areas of treatment, medical technology is evolving rapidly,” said Nicolas Guggenheim, Head of Medical Technologies at Heraeus, in a statement. Press release. “The acquisition of Mo-Sci and ETS gives us new capabilities to help our customers deliver innovative technologies and breakthrough treatments that will improve patient outcomes and care. “
Mo-Sci was founded by Delbert Day in 1985 to manufacture and sell specialty glass and ceramic products. His son, the late Ted Day, ran the business until his death in September 2020.
“Prior to his passing, Ted identified Heraeus as a privileged partner in taking Mo-Sci and ETS to the next stage of development,” Kimberly Day, owner of Mo-Sci and ETS, said in the press release. “I am happy to bring this vision to fruition. “